Literature DB >> 24990775

Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.

Rafael Ascencio-Cedillo1, Edgar Ivan López-Pulido, José Francisco Muñoz-Valle, Nicolás Villegas-Sepúlveda, Susana Del Toro-Arreola, Ciro Estrada-Chávez, Adrian Daneri-Navarro, Ramón Franco-Topete, Delia Pérez-Montiel, Alejandro García-Carrancá, Ana Laura Pereira-Suárez.   

Abstract

Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study was to determine prolactin (PRL) and PRLR expression in biopsies from patients with precursor lesions and uterine cervical cancer. PRLR expression was analyzed in 63 paraffin-embedded biopsies of uterine cervical tissue. In total, eleven low-grade squamous intraepithelial lesions (LSIL), 23 high-grade squamous intraepithelial lesions (HSIL), 21 uterine cervical cancers (UCC) and 8 normal epithelium (NE) were examined using immunoperoxidase staining and Western blot analysis. Additionally, PRL expression was identified in human cervical cancer serum and tissues. The PRLR expression was found to be significantly increased in cervical cancer in comparison with normal tissue and precursor lesions (P < 0.0003). The presence of the long isoform of the PRLR was observed only in cervical cancer tissues. Serum PRL levels were normal in all samples and local prolactin expression was similar in precursor lesions and cervical cancer by Western blot analysis. Our data suggest a possible role for PRLR in the progression of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990775     DOI: 10.1007/s12253-014-9814-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases.

Authors:  Lars Harbaum; Marion J Pollheimer; Thomas Bauernhofer; Peter Kornprat; Richard A Lindtner; Andrea Schlemmer; Peter Rehak; Cord Langner
Journal:  Mod Pathol       Date:  2010-05-07       Impact factor: 7.842

2.  Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.

Authors:  D B Paraiba; C R J Soares; P Bartolini; F S Arthuso; E F Borba; E Bonfa; M D Bronstein
Journal:  Clin Exp Rheumatol       Date:  2011-01-03       Impact factor: 4.473

3.  Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

5.  Stabilization of prolactin receptor in breast cancer cells.

Authors:  Y Li; C V Clevenger; N Minkovsky; K G S Kumar; P N Raghunath; J E Tomaszewski; V S Spiegelman; S Y Fuchs
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

6.  Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.

Authors:  I Leav; F B Merk; K F Lee; M Loda; M Mandoki; J E McNeal; S M Ho
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

7.  Prolactin as a tumour marker in cancer of the cervix.

Authors:  B G Perumal; J Moodley; R J Pegoraro
Journal:  J Obstet Gynaecol       Date:  1998-05       Impact factor: 1.246

8.  Immunocytochemical localization of prolactin in carcinoma of the cervix.

Authors:  M S Macfee; J McQueen; D E Strayer
Journal:  Gynecol Oncol       Date:  1987-03       Impact factor: 5.482

9.  Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.

Authors:  Alexander Plotnikov; Ying Li; Thai H Tran; Weigang Tang; Juan P Palazzo; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

10.  Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes.

Authors:  Gonzalo López-Rincón; Ana L Pereira-Suárez; Susana Del Toro-Arreola; Pedro E Sánchez-Hernández; Alejandra Ochoa-Zarzosa; José Francisco Muñoz-Valle; Ciro Estrada-Chávez
Journal:  J Inflamm (Lond)       Date:  2013-06-03       Impact factor: 4.981

View more
  7 in total

1.  The Choroid Plexus Is an Alternative Source of Prolactin to the Rat Brain.

Authors:  Ana R Costa-Brito; Telma Quintela; Isabel Gonçalves; Ana C Duarte; Ana R Costa; Fernando A Arosa; José E Cavaco; Manuel C Lemos; Cecília R A Santos
Journal:  Mol Neurobiol       Date:  2021-01-06       Impact factor: 5.590

2.  Differential modulation of natural killer cell cytotoxicity by 17β-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells.

Authors:  Alejandro Godoy-Pacheco; Mariel García-Chagollán; Adrián Ramírez-De-Arellano; Christian David Hernández-Silva; Julio César Villegas-Pineda; Inocencia Guadalupe Ramírez-López; José Sergio Zepeda-Nuño; Adriana Aguilar-Lemarroy; Ana Laura Pereira-Suárez
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

3.  4SC-202 exerts an anti-tumor effect in cervical cancer by targeting PRLR signaling pathway.

Authors:  Huijuan Zhang; Mingxia Li; Huiru Sun; Wen Yang; Mingxia Ye; Hua Li; Yuanguang Meng
Journal:  J Mol Histol       Date:  2022-10-22       Impact factor: 3.156

4.  Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.

Authors:  Paweł Łaniewski; Haiyan Cui; Denise J Roe; Dominique Barnes; Alison Goulder; Bradley J Monk; David L Greenspan; Dana M Chase; Melissa M Herbst-Kralovetz
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

Review 5.  The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology.

Authors:  Renata S Auriemma; Guendalina Del Vecchio; Roberta Scairati; Rosa Pirchio; Alessia Liccardi; Nunzia Verde; Cristina de Angelis; Davide Menafra; Claudia Pivonello; Alessandro Conforti; Carlo Alviggi; Rosario Pivonello; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

Review 6.  The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers.

Authors:  Adrián Ramírez-de-Arellano; Julio César Villegas-Pineda; Christian David Hernández-Silva; Ana Laura Pereira-Suárez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-21       Impact factor: 5.555

7.  Interaction between 17β-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors.

Authors:  Inocencia Guadalupe Ramírez-López; Adrián Ramírez de Arellano; Luis Felipe Jave-Suárez; Christian David Hernández-Silva; Mariel García-Chagollan; Jorge Hernández-Bello; Edgar I Lopez-Pulido; José Macias-Barragan; Margarita Montoya-Buelna; José Francisco Muñoz-Valle; Ana Laura Pereira-Suárez
Journal:  Cancer Cell Int       Date:  2019-09-02       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.